The startup that offers to couple with what the client already uses sells more than the startup that offers to replace it.
In B2B markets with entrenched legacy systems (healthcare, industry, agribusiness, large corporations), "replace everything" is a toxic proposition. The client has years of process shaped around the current system, people trained on the existing workflow, invisible dependencies (financial reports, regulatory integrations, leadership habits), and justified fear of migration.
The startup that walks in proposing replacement meets active resistance. The one that walks in proposing coupling ("it sits on top of what you already have, it fills in what's missing") wins without a fight.
I've seen this truth repeat itself in two completely different domains:
- B2B healthtech (Huna, health insurers such as Unimed VTRP, Unimed Caruaru, Pipo): the health insurer rejects proposals asking to replace the electronic health record; it accepts proposals that couple with the existing record.
- B2B integrations (Wehandle): the client pays for the integration that connects existing systems; it discards "innovation" projects that require swapping out the core platform.
The strategic rule that comes out of this: if the product requires the client to abandon something, the product is positioned wrong. Repackage it as a complement, not a substitute, before you keep trying to sell it.